Overview

Phase IV-Cervical Dystonia-INTEREST IN CD2

Status:
Active, not recruiting

Trial end date:
0000-00-00

Target enrollment:

Participant gender:

Summary

The purpose of the study is to document long-term response in real-life practice after injection cycles with BoNT-A in subjects suffering from idiopathic cervical dystonia (Long-term clinical and pharmaco-economic data).

Phase:

N/A

Details

Lead Sponsor:

Ipsen

Treatments:

incobotulinumtoxinA